The CXCL12-CXCR4/CXCR7 axis plays a multifaceted role in ESCA pathogenesis, with extensive experimental and clinical evidence supporting its involvement in tumor progression and therapeutic resistance. This evidence concerns the gene CXCL12 and neoplasm.